Literature DB >> 18575463

Mid-frequency DFNA8/12 hearing loss caused by a synonymous TECTA mutation that affects an exonic splice enhancer.

Rob W J Collin1, Anne-Martine R de Heer, Jaap Oostrik, Robert-Jan Pauw, Rutger F Plantinga, Patrick L Huygen, Ronald Admiraal, Arjan P M de Brouwer, Tim M Strom, Cor W R J Cremers, Hannie Kremer.   

Abstract

Autosomal dominant hearing loss is highly heterogeneous. Hearing impairment mainly involves the mid-frequencies (500-2000 Hz) in only a low percentage of the cases. In a Dutch family with autosomal dominant mid-frequency/flat hearing loss, genome-wide SNP analysis combined with fine mapping using microsatellite markers mapped the defect to the DFNA8/12 locus, with a maximum two-point LOD score of 3.52. All exons and intron-exon boundaries of the TECTA gene, of which mutations are causative for DFNA8/12, were sequenced. Only one heterozygous synonymous change in exon 16 (c.5331G>A; p.L1777L) was found to segregate with the hearing loss. This change was predicted to cause the loss of an exonic splice enhancer (ESE). RT-PCR using primers flanking exon 16 revealed, besides the expected PCR product from the wild-type allele, a smaller fragment only in the affected individual, representing part of an aberrant TECTA transcript lacking exon 16. The aberrant splicing is predicted to result in a deletion of 37 amino acids (p.S1758Y/G1759_N1795del) in alpha-tectorin. Subsequently, the same mutation was detected in two out of 36 individuals with a comparable phenotype. Owing to the position of the protein deletion just N-terminal of the zona pellucida (ZP) domain of alpha-tectorin, it is likely that the deletion of 37 amino acids may affect the proteolytic processing, structure and/or function of this domain, which results in a clinical phenotype comparable to that of missense mutations in the ZP domain. In addition, this is the first report of a synonymous mutation that affects an ESE and causes hereditary hearing loss.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18575463     DOI: 10.1038/ejhg.2008.110

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  15 in total

1.  Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia.

Authors:  A Piton; J Gauthier; F F Hamdan; R G Lafrenière; Y Yang; E Henrion; S Laurent; A Noreau; P Thibodeau; L Karemera; D Spiegelman; F Kuku; J Duguay; L Destroismaisons; P Jolivet; M Côté; K Lachapelle; O Diallo; A Raymond; C Marineau; N Champagne; L Xiong; C Gaspar; J-B Rivière; J Tarabeux; P Cossette; M-O Krebs; J L Rapoport; A Addington; L E Delisi; L Mottron; R Joober; E Fombonne; P Drapeau; G A Rouleau
Journal:  Mol Psychiatry       Date:  2010-05-18       Impact factor: 15.992

2.  Biophysical mechanisms underlying outer hair cell loss associated with a shortened tectorial membrane.

Authors:  Christopher C Liu; Simon S Gao; Tao Yuan; Charles Steele; Sunil Puria; John S Oghalai
Journal:  J Assoc Res Otolaryngol       Date:  2011-05-13

3.  A comparative analysis of genetic hearing loss phenotypes in European/American and Japanese populations.

Authors:  W Daniel Walls; Hideaki Moteki; Taylor R Thomas; Shin-Ya Nishio; Hidekane Yoshimura; Yoichiro Iwasa; Kathy L Frees; Carla J Nishimura; Hela Azaiez; Kevin T Booth; Robert J Marini; Diana L Kolbe; A Monique Weaver; Amanda M Schaefer; Kai Wang; Terry A Braun; Shin-Ichi Usami; Peter G Barr-Gillespie; Guy P Richardson; Richard J Smith; Thomas L Casavant
Journal:  Hum Genet       Date:  2020-05-07       Impact factor: 4.132

4.  Analysis of the effects of rare variants on splicing identifies alterations in GABAA receptor genes in autism spectrum disorder individuals.

Authors:  Amélie Piton; Loubna Jouan; Daniel Rochefort; Sylvia Dobrzeniecka; Karine Lachapelle; Patrick A Dion; Julie Gauthier; Guy A Rouleau
Journal:  Eur J Hum Genet       Date:  2012-11-21       Impact factor: 4.246

5.  A novel mutation of EYA4 in a large Chinese family with autosomal dominant middle-frequency sensorineural hearing loss by targeted exome sequencing.

Authors:  Yi Sun; Zhao Zhang; Jing Cheng; Yu Lu; Chang-Liang Yang; Yan-Yun Luo; Guang Yang; Hui Yang; Li Zhu; Jia Zhou; Hang-Qi Yao
Journal:  J Hum Genet       Date:  2015-03-26       Impact factor: 3.172

6.  DFNA8/12 caused by TECTA mutations is the most identified subtype of nonsyndromic autosomal dominant hearing loss.

Authors:  Michael S Hildebrand; Matías Morín; Nicole C Meyer; Fernando Mayo; Silvia Modamio-Hoybjor; Angeles Mencía; Leticia Olavarrieta; Carmelo Morales-Angulo; Carla J Nishimura; Heather Workman; Adam P DeLuca; Ignacio del Castillo; Kyle R Taylor; Bruce Tompkins; Corey W Goodman; Isabelle Schrauwen; Maarten Van Wesemael; K Lachlan; A Eliot Shearer; Terry A Braun; Patrick L M Huygen; Hannie Kremer; Guy Van Camp; Felipe Moreno; Thomas L Casavant; Richard J H Smith; Miguel A Moreno-Pelayo
Journal:  Hum Mutat       Date:  2011-06-07       Impact factor: 4.878

7.  Evidence in disease and non-disease contexts that nonsense mutations cause altered splicing via motif disruption.

Authors:  Liam Abrahams; Rosina Savisaar; Christine Mordstein; Bethan Young; Grzegorz Kudla; Laurence D Hurst
Journal:  Nucleic Acids Res       Date:  2021-09-27       Impact factor: 16.971

Review 8.  Research progress in pathogenic genes of hereditary non-syndromic mid-frequency deafness.

Authors:  Wenjun Xia; Fei Liu; Duan Ma
Journal:  Front Med       Date:  2016-05-03       Impact factor: 4.592

9.  A systematic approach to assessing the clinical significance of genetic variants.

Authors:  H Duzkale; J Shen; H McLaughlin; A Alfares; M A Kelly; T J Pugh; B H Funke; H L Rehm; M S Lebo
Journal:  Clin Genet       Date:  2013-11       Impact factor: 4.438

Review 10.  Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges.

Authors:  Shahar Taiber; Karen B Avraham
Journal:  Neurosci Lett       Date:  2019-10-03       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.